Literature DB >> 9440590

Diagnostic and management strategies for diffuse interstitial lung disease.

H Y Reynolds1.   

Abstract

Patients with diffuse interstitial lung diseases (DILD) are challenging to treat. Many patients with DILD have inadequate information about the disease process, an imprecise diagnosis, unsatisfactory treatment or unacceptable side effects associated with therapy, and poorly controlled symptoms of progressive illness. Establishing an accurate diagnosis is necessary so that the patient and his/her family can be provided with reasonable expectations about prognosis and outcome from therapy. A pragmatic approach is presented that emphasizes diagnostic strategies and plans for therapy that are effective and resource efficient and that will help maintain patient satisfaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440590     DOI: 10.1378/chest.113.1.192

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Pulmonary function testing in idiopathic interstitial pneumonias.

Authors:  Fernando J Martinez; Kevin Flaherty
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 2.  Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.

Authors:  Herbert Y Reynolds
Journal:  Lung       Date:  2011-02-25       Impact factor: 2.584

3.  Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer.

Authors:  Taichiro Goto; Arafumi Maeshima; Yoshitaka Oyamada; Ryoichi Kato
Journal:  Int J Clin Oncol       Date:  2013-05-10       Impact factor: 3.402

4.  Significance of myositis autoantibody in patients with idiopathic interstitial lung disease.

Authors:  Ju Sun Song; Jiwon Hwang; Hoon-Suk Cha; Byeong-Ho Jeong; Gee Young Suh; Man Pyo Chung; Eun-Suk Kang
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

5.  Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.

Authors:  Evgeni Gershman; Alona Zer; Barak Pertzov; Osnat Shtraichman; Dorit Shitenberg; Moshe Heching; Dror Rosengarten; Mordechai Kramer
Journal:  BMJ Open Respir Res       Date:  2020-06

6.  Silencing of heart and neural crest derivatives expressed transcript 2 attenuates transforming growth factor-β1-enhanced apoptosis of human bronchial epithelial cells.

Authors:  Xiaohui Jiang
Journal:  Oncol Lett       Date:  2018-08-13       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.